StockData
Aptevo Therapeutics Inc. logo

Aptevo Therapeutics Inc. (APVO) stock

APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.45−0.02 (-3.25%)

Close on Nov 18, 2026Market cap $803.68KP/E –Yield –

Aptevo Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Aptevo Therapeutics's pe ratio was 44.4× on Jul 31, 2023.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jul 31, 202344.4×–

More Aptevo Therapeutics figures

See a number that looks wrong?